Tocilizumab Controls Paraneoplastic Inflammatory Syndrome but Does Not Suppress Tumor Growth of Angiomatoid Fibrous Histiocytoma.

Sabe, Hideaki; Inoue, Akitomo; Nagata, Shigenori; Imura, Yoshinori; Wakamatsu, Toru; Takenaka, Satoshi; Tamiya, Hironari

Sabe, Hideaki; Inoue, Akitomo; Nagata, Shigenori; Imura, Yoshinori; Wakamatsu, Toru; Takenaka, Satoshi; Tamiya, Hironari.

Afiliación

Sabe H; Department of Orthopedic Surgery, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Inoue A; Department of Orthopedic Surgery, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Nagata S; Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Imura Y; Department of Orthopedic Surgery, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Wakamatsu T; Department of Orthopedic Surgery, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Takenaka S; Department of Orthopedic Surgery, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Tamiya H; Department of Orthopedic Surgery, Osaka International Cancer Institute, Osaka 541-8567, Japan.

Case Rep Oncol Med ; 2021: 5532258, 2021.

Article en En | MEDLINE | ID: mdl-34221525

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Case Rep Oncol Med Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google